Literature DB >> 22554193

Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis.

Brijesh Srivastava1, George F Mells, Heather J Cordell, Agnes Muriithi, Matthew Brown, Eva Ellinghaus, Andre Franke, Tom H Karlsen, Richard N Sandford, Graeme J Alexander, Roger W Chapman, Simon M Rushbrook, Espen Melum.   

Abstract

BACKGROUND AND AIMS: Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by progressive inflammation and fibrosis of the bile ducts eventually leading to biliary cirrhosis. Recent genetic studies in PSC have identified associations at 2q13, 2q35, 3p21, 4q27, 13q31 and suggestive association at 10p15. The aim of this study was to further characterize and refine the genetic architecture of PSC.
METHODS: We analyzed previously reported associated SNPs at four of these non-HLA loci and 59 SNPs tagging the IL-2/IL-21 (4q27) and IL2RA (10p15) loci in 992 UK PSC cases and 5162 healthy UK controls.
RESULTS: The most associated SNPs identified were rs3197999 (3p21 (MST1), p = 1.9 × 10⁻⁶, OR(A vs G) = 1.28, 95% CI (1.16-1.42)); rs4147359 (10p15 (IL2RA), p = 2.6 × 10⁻⁴, OR(A vs G) = 1.20, 95% CI (1.09-1.33)) and rs12511287 (4q27 (IL-2/IL-21), p = 3.0 × 10⁻⁴, OR(A vs T) = 1.21, 95% CI (1.09-1.35)). In addition, we performed a meta-analysis for selected SNPs using published summary statistics from recent studies. We observed genome-wide significance for rs3197999 (3p21 (MST1), P (combined) = 3.8 × 10⁻¹²) and rs4147359 (10p15 (IL2RA), P (combined) = 1.5 × 10⁻⁸).
CONCLUSION: We have for the first time confirmed the association of PSC with genetic variants at 10p15 (IL2RA) locus at genome-wide significance and replicated the associations at MST1 and IL-2/IL-21 loci in a large homogeneous UK population. These results strongly implicate the role of IL-2/IL2RA pathway in PSC and provide further confirmation of MST1 association.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22554193     DOI: 10.3109/00365521.2012.682090

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  13 in total

Review 1.  Genetics in PSC: what do the "risk genes" teach us?

Authors:  Trine Folseraas; Evaggelia Liaskou; Carl A Anderson; Tom H Karlsen
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

Review 2.  Genetics of primary sclerosing cholangitis and pathophysiological implications.

Authors:  Xiaojun Jiang; Tom H Karlsen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-03-15       Impact factor: 46.802

Review 3.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

Review 4.  The enteric microbiome in hepatobiliary health and disease.

Authors:  James H Tabibian; Cyril Varghese; Nicholas F LaRusso; Steven P O'Hara
Journal:  Liver Int       Date:  2015-12-12       Impact factor: 5.828

5.  Functional consequences of the macrophage stimulating protein 689C inflammatory bowel disease risk allele.

Authors:  Steven E Kauder; Lydia Santell; Elaine Mai; Lilyan Y Wright; Elizabeth Luis; Elsa N N'Diaye; Jeff Lutman; Navneet Ratti; Susan M Sa; Henry R Maun; Eric Stefanich; Lino C Gonzalez; Robert R Graham; Lauri Diehl; William A Faubion; Mary E Keir; Judy Young; Amitabha Chaudhuri; Robert A Lazarus; Jackson G Egen
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 6.  The Role of Genetic and Immune Factors for the Pathogenesis of Primary Sclerosing Cholangitis in Childhood.

Authors:  Priscila Menezes Ferri; Ana Cristina Simões E Silva; Soraya Luiza Campos Silva; Diego Junior Queiroga de Aquino; Eleonora Druve Tavares Fagundes; Débora Marques de Miranda; Alexandre Rodrigues Ferreira
Journal:  Gastroenterol Res Pract       Date:  2016-11-02       Impact factor: 2.260

7.  Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease.

Authors:  Sun-Gou Ji; Brian D Juran; Sören Mucha; Trine Folseraas; Luke Jostins; Espen Melum; Natsuhiko Kumasaka; Elizabeth J Atkinson; Erik M Schlicht; Jimmy Z Liu; Tejas Shah; Javier Gutierrez-Achury; Kirsten M Boberg; Annika Bergquist; Severine Vermeire; Bertus Eksteen; Peter R Durie; Martti Farkkila; Tobias Müller; Christoph Schramm; Martina Sterneck; Tobias J Weismüller; Daniel N Gotthardt; David Ellinghaus; Felix Braun; Andreas Teufel; Mattias Laudes; Wolfgang Lieb; Gunnar Jacobs; Ulrich Beuers; Rinse K Weersma; Cisca Wijmenga; Hanns-Ulrich Marschall; Piotr Milkiewicz; Albert Pares; Kimmo Kontula; Olivier Chazouillères; Pietro Invernizzi; Elizabeth Goode; Kelly Spiess; Carmel Moore; Jennifer Sambrook; Willem H Ouwehand; David J Roberts; John Danesh; Annarosa Floreani; Aliya F Gulamhusein; John E Eaton; Stefan Schreiber; Catalina Coltescu; Christopher L Bowlus; Velimir A Luketic; Joseph A Odin; Kapil B Chopra; Kris V Kowdley; Naga Chalasani; Michael P Manns; Brijesh Srivastava; George Mells; Richard N Sandford; Graeme Alexander; Daniel J Gaffney; Roger W Chapman; Gideon M Hirschfield; Mariza de Andrade; Simon M Rushbrook; Andre Franke; Tom H Karlsen; Konstantinos N Lazaridis; Carl A Anderson
Journal:  Nat Genet       Date:  2016-12-19       Impact factor: 38.330

Review 8.  Current understanding of primary biliary cholangitis.

Authors:  Atsushi Tanaka
Journal:  Clin Mol Hepatol       Date:  2020-12-03

9.  Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

Authors:  Jimmy Z Liu; Johannes Roksund Hov; Trine Folseraas; Eva Ellinghaus; Simon M Rushbrook; Nadezhda T Doncheva; Ole A Andreassen; Rinse K Weersma; Tobias J Weismüller; Bertus Eksteen; Pietro Invernizzi; Gideon M Hirschfield; Daniel Nils Gotthardt; Albert Pares; David Ellinghaus; Tejas Shah; Brian D Juran; Piotr Milkiewicz; Christian Rust; Christoph Schramm; Tobias Müller; Brijesh Srivastava; Georgios Dalekos; Markus M Nöthen; Stefan Herms; Juliane Winkelmann; Mitja Mitrovic; Felix Braun; Cyriel Y Ponsioen; Peter J P Croucher; Martina Sterneck; Andreas Teufel; Andrew L Mason; Janna Saarela; Virpi Leppa; Ruslan Dorfman; Domenico Alvaro; Annarosa Floreani; Suna Onengut-Gumuscu; Stephen S Rich; Wesley K Thompson; Andrew J Schork; Sigrid Næss; Ingo Thomsen; Gabriele Mayr; Inke R König; Kristian Hveem; Isabelle Cleynen; Javier Gutierrez-Achury; Isis Ricaño-Ponce; David van Heel; Einar Björnsson; Richard N Sandford; Peter R Durie; Espen Melum; Morten H Vatn; Mark S Silverberg; Richard H Duerr; Leonid Padyukov; Stephan Brand; Miquel Sans; Vito Annese; Jean-Paul Achkar; Kirsten Muri Boberg; Hanns-Ulrich Marschall; Olivier Chazouillères; Christopher L Bowlus; Cisca Wijmenga; Erik Schrumpf; Severine Vermeire; Mario Albrecht; John D Rioux; Graeme Alexander; Annika Bergquist; Judy Cho; Stefan Schreiber; Michael P Manns; Martti Färkkilä; Anders M Dale; Roger W Chapman; Konstantinos N Lazaridis; Andre Franke; Carl A Anderson; Tom H Karlsen
Journal:  Nat Genet       Date:  2013-04-21       Impact factor: 38.330

10.  Clinical guidelines for primary sclerosing cholangitis 2017.

Authors:  Hiroyuki Isayama; Susumu Tazuma; Norihiro Kokudo; Atsushi Tanaka; Toshio Tsuyuguchi; Takahiro Nakazawa; Kenji Notohara; Suguru Mizuno; Nobuhisa Akamatsu; Masahiro Serikawa; Itaru Naitoh; Yoshiki Hirooka; Toshifumi Wakai; Takao Itoi; Tomoki Ebata; Shinji Okaniwa; Terumi Kamisawa; Hiroki Kawashima; Atsushi Kanno; Keiichi Kubota; Masami Tabata; Michiaki Unno; Hajime Takikawa
Journal:  J Gastroenterol       Date:  2018-06-27       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.